ArticleEnvironmental epidemiology (Philadelphia, Pa.)2026
Prediction of endometrial tissue PFAS concentrations using serum levels, demographic, and reproductive factors: Findings from the Investigating Mixtures of Pollutants and Endometriosis in Tissue (IMPLANT) study.
Article in Environmental epidemiology (Philadelphia, Pa.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Per- and polyfluoroalkyl substances (PFAS) accumulate in reproductive tissues, yet most studies rely on serum measurements. It remains unclear whether serum concentrations adequately reflect levels in target tissues. We evaluated whether serum PFAS predicts endometrial tissue concentrations and examined associations with endometriosis. Methods: The Investigating Mixtures of Pollutants and Endometriosis in Tissue study included 433 reproductive-aged women undergoing laparoscopy or laparotomy in Salt Lake City, Utah, and San Francisco, California. Nine PFAS-perfluorooctane sulfonic acid (PFOS), perfluorohexane sulfonic acid (PFHxS), perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), perfluoroundecanoic acid (PFUnDA), perfluorododecanoic acid (PFDoDA), perfluoroheptanoic acid (PFHpA), and perfluorooctane sulfonamide (PFOSA)-were quantified in matched serum (ng/mL) and endometrial tissue (ng/g) using high-performance liquid chromatography with tandem mass spectrometry. Values below the limit of detection were multiply imputed. Linear regression estimated log-transformed tissue concentrations from serum PFAS and covariates. Logistic regression estimated odds ratios (ORs) for endometriosis. Composite variables were created by summing log-transformed concentrations of short-chain PFAS (<8 carbons: PFHpA, PFHxS, PFOA, and PFOS) and long-chain PFAS (≥8 carbons: PFNA, PFDA, PFUnDA, PFDoDA, and PFOSA). Results: Serum PFAS was moderately associated with tissue levels, with the strongest performance for PFOS (R Conclusions: Serum PFAS minimally reflect endometrial tissue burden, with variability by chain length. While serum remains practical for large studies, tissue-based measures may provide more accurate estimates of exposure in tissue. These findings inform PFAS-endometriosis research and may extend to other gynecologic conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.